458 related articles for article (PubMed ID: 26826546)
1. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
2. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
3. Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.
Cibulski SP; Rivera-Patron M; Mourglia-Ettlin G; Casaravilla C; Yendo ACA; Fett-Neto AG; Chabalgoity JA; Moreno M; Roehe PM; Silveira F
Sci Rep; 2018 Sep; 8(1):13582. PubMed ID: 30206376
[TBL] [Abstract][Full Text] [Related]
4. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
[TBL] [Abstract][Full Text] [Related]
5. Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice.
Cibulski SP; Silveira F; Mourglia-Ettlin G; Teixeira TF; dos Santos HF; Yendo AC; de Costa F; Fett-Neto AG; Gosmann G; Roehe PM
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():1-8. PubMed ID: 27012913
[TBL] [Abstract][Full Text] [Related]
6. Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.
de Costa F; Yendo AC; Cibulski SP; Fleck JD; Roehe PM; Spilki FR; Gosmann G; Fett-Neto AG
PLoS One; 2014; 9(8):e105374. PubMed ID: 25148077
[TBL] [Abstract][Full Text] [Related]
7. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses.
Sjölander A; van't Land B; Lövgren Bengtsson K
Cell Immunol; 1997 Apr; 177(1):69-76. PubMed ID: 9140097
[TBL] [Abstract][Full Text] [Related]
8. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
9. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.
Fleck JD; Kauffmann C; Spilki F; Lencina CL; Roehe PM; Gosmann G
Vaccine; 2006 Nov; 24(49-50):7129-34. PubMed ID: 16887242
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis.
da Fonseca DP; Frerichs J; Singh M; Snippe H; Verheul AF
Vaccine; 2000 Aug; 19(1):122-31. PubMed ID: 10924794
[TBL] [Abstract][Full Text] [Related]
12. Saponins from
Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
[No Abstract] [Full Text] [Related]
13. Foamy matters: an update on
Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
Rönnberg B; Fekadu M; Morein B
Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
[TBL] [Abstract][Full Text] [Related]
16. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
17. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
[TBL] [Abstract][Full Text] [Related]
18. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
[TBL] [Abstract][Full Text] [Related]
19. ISCOMs and ISCOMATRIX.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
[TBL] [Abstract][Full Text] [Related]
20. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
de Groot C; Müller-Goymann CC
Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
